221 related articles for article (PubMed ID: 6278131)
1. gamma-Aminobutyric acid (GABA) receptor stimulation. IV. Effect of progabide (SL 76002) and other GABAergic agents on acetylcholine turnover in rat brain areas.
Scatton B; Bartholini G
J Pharmacol Exp Ther; 1982 Mar; 220(3):689-95. PubMed ID: 6278131
[No Abstract] [Full Text] [Related]
2. gamma-Aminobutyric acid (GABA) receptor stimulation. III. Effect of progabide (SL 76002) on norepinephrine, dopamine and 5-hydroxytryptamine turnover in rat brain areas.
Scatton B; Zivkovic B; Dedek J; Lloyd KG; Constantinidis J; Tissot R; Bartholini G
J Pharmacol Exp Ther; 1982 Mar; 220(3):678-88. PubMed ID: 6278130
[No Abstract] [Full Text] [Related]
3. gamma-Aminobutyric acid (GABA) receptor stimulation. II. Specificity of progabide (SL 76002) and SL 75102 for the GABA receptor.
Lloyd KG; Arbilla S; Beaumont K; Briley M; De Montis G; Scatton B; Langer SZ; Bartholini G
J Pharmacol Exp Ther; 1982 Mar; 220(3):672-7. PubMed ID: 6121050
[TBL] [Abstract][Full Text] [Related]
4. gamma-Aminobutyric acid (GABA) receptor stimulation. I. Neuropharmacological profiles of progabide (SL 76002) and SL 75102, with emphasis on their anticonvulsant spectra.
Worms P; Depoortere H; Durand A; Morselli PL; Lloyd KG; Bartholini G
J Pharmacol Exp Ther; 1982 Mar; 220(3):660-71. PubMed ID: 6278129
[TBL] [Abstract][Full Text] [Related]
5. Actions of GABAergic agents on dopamine metabolism in the nigrostriatal pathway of the rat.
Wood PL
J Pharmacol Exp Ther; 1982 Sep; 222(3):674-9. PubMed ID: 6286931
[TBL] [Abstract][Full Text] [Related]
6. Pantoyl-gamma-aminobutyric acid facilitates cholinergic function in the central nervous system.
Nakahiro M; Fujita N; Fukuchi I; Saito K; Nishimura T; Yoshida H
J Pharmacol Exp Ther; 1985 Feb; 232(2):501-6. PubMed ID: 2982013
[TBL] [Abstract][Full Text] [Related]
7. Effects of GABAergic drugs on the GABA turnover in the substantia nigra and the corpus striatum of the rat.
Lindgren S
J Neural Transm; 1987; 69(1-2):33-46. PubMed ID: 3035084
[TBL] [Abstract][Full Text] [Related]
8. Further evidence for, and nature of, the facilitatory GABAergic influence on central noradrenergic transmission.
Dennis T; Curet O; Nishikawa T; Scatton B
Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):225-34. PubMed ID: 3003590
[TBL] [Abstract][Full Text] [Related]
9. Dopaminergic, GABA-ergic and cholinergic interaction in the regulation of striatal acetylcholine concentration.
Sethy VH
Res Commun Chem Pathol Pharmacol; 1978 Aug; 21(2):359-62. PubMed ID: 358340
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of gamma-aminobutyric acid release by gamma-aminobutyric acid agonist drugs. Pharmacology of the gamma-aminobutyric acid autoreceptor.
Brennan MJ; Cantrill RC; Oldfield M; Krogsgaard-Larsen P
Mol Pharmacol; 1981 Jan; 19(1):27-30. PubMed ID: 6259511
[No Abstract] [Full Text] [Related]
11. Pharmacology of the GABAergic system: effects of progabide, a GABA receptor agonist.
Bartholini G
Psychoneuroendocrinology; 1984; 9(2):135-40. PubMed ID: 6089242
[TBL] [Abstract][Full Text] [Related]
12. Effect of the new gamma-aminobutyric acid agonist SL 76 002 on striatal acetylcholine: relation to neuroleptic-induced extrapyramidal alterations.
Bartholini G; Scatton B; Zivkovic B
Adv Biochem Psychopharmacol; 1980; 24():207-13. PubMed ID: 6105775
[TBL] [Abstract][Full Text] [Related]
13. Differential effect of gamma-aminobutyric acid on benzodiazepine receptor subtypes labeled by [3H]propyl beta-carboline-3-carboxylate in rat brain.
Gee KW; Ehlert FJ; Yamamura HI
J Pharmacol Exp Ther; 1983 Apr; 225(1):132-7. PubMed ID: 6300371
[No Abstract] [Full Text] [Related]
14. Brain receptor binding of analogues of gamma-aminobutyric acid (GABA).
Borea PA; Bonora A; Baraldi PG; Simoni D
Farmaco Sci; 1983 Jun; 38(6):411-7. PubMed ID: 6307745
[TBL] [Abstract][Full Text] [Related]
15. The effect of gamma-aminobutyric acid on the content and metabolism of acetylcholine in the rat striatum.
Kleinrok A
Pol J Pharmacol Pharm; 1979; 31(5):481-7. PubMed ID: 547277
[TBL] [Abstract][Full Text] [Related]
16. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
Hossain MA; Weiner N
J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
[TBL] [Abstract][Full Text] [Related]
17. Increase in striatal acetylcholine levels by GABAergic agents: dependence on corticostriatal neurons.
Scatton B; Bartholini G
Brain Res; 1980 Oct; 200(1):174-8. PubMed ID: 6774796
[TBL] [Abstract][Full Text] [Related]
18. GABAergic mechanisms in blood pressure control. A pharmacological analysis in the rat.
Persson B
Acta Physiol Scand Suppl; 1980; 491():1-54. PubMed ID: 6111893
[No Abstract] [Full Text] [Related]
19. Drug-induced alterations in neurotransmitter receptor binding and function.
Enna SJ; Ferkany JW; Strong R
Adv Biochem Psychopharmacol; 1980; 21():253-63. PubMed ID: 6246740
[No Abstract] [Full Text] [Related]
20. Selective blockade of type-1 metabotropic glutamate receptors induces neuroprotection by enhancing gabaergic transmission.
Battaglia G; Bruno V; Pisani A; Centonze D; Catania MV; Calabresi P; Nicoletti F
Mol Cell Neurosci; 2001 Jun; 17(6):1071-83. PubMed ID: 11414795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
